INTERACTIVE
WEBINAR

 
Call-in teleconferencing
 
Video demonstrations included in the presentation
 
 
 
610-399-4897
 


 

 

 
 

 
HOW PROCESS AND PROCESS EQUIPMENT CAN IMPROVE REGULATORY AND SAFETY CONSIDERATIONS
 

 
 August 19 2009 WEBINAR
Noon. - 1:30 p.m.. Eastern Daylight Time (EDT)

    Often simple changes can significantly improve processes especially in regards to cross contamination and operator exposure control.  This session looks at the factors that lead to the selection of inappropriate technologies and set up that may be expeditious at the early development stage but which lead to operational inadequacies during the product lifecycle.  Improvement requires cooperation over many disciplines and a change in attitude by many stakeholders. The downside of not getting this right is that others will.  The session is of especial relevance to those in the Generic and CMO areas with multi product facilities


    This webinar will guide you through the thinking and rationale behind selecting processes and equipment that will reduce the risk of cross contamination and operator exposure.

    In this webinar you will learn about:
    • Optimizing the process for positive benefit
    • Overcoming the “ We cannot change it attitude”
    • Equipment issues
    • Exposure issues
    • Functionality and Ergonomics
    • Material Handling issues
    • Facility implications with closed systems
    • Putting it all together
    Instructor:  Julian Wilkins Dip, Arch. (Oxford) RIBA, VP PharmaConsult US, Inc, Adjunct Professor Stevens Institute
    Julian Wilkins is founder and vice president with PharmaConsult US, Inc. In 1991 he founded a UK based isolator company for the emerging need for pharmaceutical containment. The company carried out many projects worldwide for aseptic and potent containment at all scales of pharmaceutical operation. He moved to the US in 1997 and set up PharmaConsult US in 1999. Since its formation, the company has provided independent advice, design and support for containment projects including Bristol-Myers Squibb, Chiron, GSK, Merck & Co., Pfizer, Roche Colorado, Sanofi Sythelabo, Tyco/ Mallinckrodt and Wyeth. Wilkins is a past recipient of the prestigious ISPE Member of the Year award. Mr. Wilkins has spoken at many seminars worldwide on the subject of containment and has contributed articles and chapters to periodicals and books on containment.
     
     
     FEE: $345 for one person.
    Call for special discounts for multiple participants from your company.
     
    610-399-4897
     
    ECCWEB122